Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
Beate KampmannShabir Ahmed MadhiIona MunjalEric A F SimõesBarbara A PahudConrado LlapurJeffrey BakerGonzalo Pérez MarcDavid RadleyEmma ShittuJulia R GlanternikHasra SnaggsJames BaberPhilip ZachariahShaun L BarnabasMerlin FausettTyler AdamNicole PerrerasMarlies A Van HoutenAnu KanteleLi-Min HuangLouis J BontTakeo OtsukiSergio L VargasJoanna GullamBruce TapieroRenato T SteinFernando P PolackHeather J ZarNina B StaerkeMaría Duron PadillaPeter C RichmondKenneth KouryKatherine SchneiderElena V KalininaDavid CooperKathrin U JansenAnnaliesa S AndersonKena A SwansonWilliam C GruberAlejandra Gurtmannull nullPublished in: The New England journal of medicine (2023)
RSVpreF vaccine administered during pregnancy was effective against medically attended severe RSV-associated lower respiratory tract illness in infants, and no safety concerns were identified. (Funded by Pfizer; MATISSE ClinicalTrials.gov number, NCT04424316.).